Journal: Pharmaceuticals
Article Title: Positive Allosteric Modulators of Trk Receptors for the Treatment of Alzheimer’s Disease
doi: 10.3390/ph17080997
Figure Lengend Snippet: Schematic representation of Trk signaling pathways. The arrows on the upper part indicate suggested sites for interaction between small-molecule modulators and Trk receptors. Phosphotyrosine residues on TrkA are highlighted in yellow circles. Some phosphotyrosine residues are numbered according to the amino acid sequence of TrkA and their interaction with adaptor proteins SHC1, PI3K, and PLCγ are indicated. Functional outcomes are depicted in light blue boxes with citations in square brackets. The figure was created with BioRender.com ( https://biorender.com , accessed on 16 June 2024).
Article Snippet: First, Eisai has described a small set of molecules acting as biased positive allosteric modulators of TrkA [ ] and has presented both preclinical and clinical data for E2511 at several international conferences [ , , ].
Techniques: Protein-Protein interactions, Sequencing, Functional Assay